Shares of American International Group, Inc. (NYSE:AIG – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the sixteen analysts that are currently covering the firm, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $84.38.
AIG has been the subject of several research reports. Bank of America increased their price objective on shares of American International Group from $82.00 to $86.00 and gave the company a “neutral” rating in a report on Thursday, October 10th. Piper Sandler reduced their target price on shares of American International Group from $89.00 to $86.00 and set an “overweight” rating for the company in a report on Friday, August 2nd. Keefe, Bruyette & Woods dropped their target price on shares of American International Group from $96.00 to $90.00 and set an “outperform” rating on the stock in a research report on Monday, August 12th. UBS Group lifted their target price on American International Group from $84.00 to $88.00 and gave the stock a “buy” rating in a report on Tuesday, October 15th. Finally, Barclays began coverage on shares of American International Group in a report on Wednesday, September 4th. They issued an “overweight” rating and a $90.00 price target on the stock.
Check Out Our Latest Report on AIG
Insider Buying and Selling
Institutional Trading of American International Group
Institutional investors have recently modified their holdings of the stock. Christopher J. Hasenberg Inc acquired a new stake in American International Group in the 3rd quarter worth about $26,000. Fortitude Family Office LLC increased its position in shares of American International Group by 199.2% during the second quarter. Fortitude Family Office LLC now owns 359 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 239 shares in the last quarter. Y.D. More Investments Ltd acquired a new position in American International Group in the 2nd quarter valued at $27,000. Versant Capital Management Inc raised its stake in American International Group by 326.0% in the 2nd quarter. Versant Capital Management Inc now owns 443 shares of the insurance provider’s stock valued at $33,000 after purchasing an additional 339 shares during the last quarter. Finally, Ashton Thomas Securities LLC purchased a new position in American International Group in the 3rd quarter valued at $46,000. Institutional investors and hedge funds own 90.60% of the company’s stock.
American International Group Price Performance
NYSE AIG opened at $76.33 on Tuesday. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.22. American International Group has a 52 week low of $62.52 and a 52 week high of $80.83. The firm has a market capitalization of $49.15 billion, a P/E ratio of -59.17, a PEG ratio of 5.23 and a beta of 1.05. The company has a 50-day moving average price of $75.13 and a 200-day moving average price of $75.63.
American International Group Company Profile
American International Group, Inc offers insurance products for commercial, institutional, and individual customers in North America and internationally. It operates through three segments: General Insurance, Life and Retirement, and Other Operations. The General Insurance segment provides commercial and industrial property insurance, including business interruption and package insurance that cover exposure to made and natural disasters; general liability, environmental, commercial automobile liability, workers’ compensation, excess casualty, and crisis management insurance products; and professional liability insurance.
Featured Stories
- Five stocks we like better than American International Group
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Intel: Is Now the Time to Be Brave?Â
- The How And Why of Investing in Oil Stocks
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Upcoming IPO Stock Lockup Period, Explained
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for American International Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American International Group and related companies with MarketBeat.com's FREE daily email newsletter.